Scorpius Holdings Files 8-K on Agreements and Obligations
Ticker: SCPX · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1476963
| Field | Detail |
|---|---|
| Company | Scorpius Holdings, Inc. (SCPX) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-obligation, equity-sale
Related Tickers: SCPX
TL;DR
Scorpius Holdings (SCPX) dropped an 8-K detailing new deals and debt. Watch this space.
AI Summary
Scorpius Holdings, Inc. (formerly NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.) filed an 8-K on May 30, 2025, reporting a material definitive agreement, a direct financial obligation, and unregistered sales of equity securities. The company, incorporated in Delaware with its principal office in San Antonio, TX, operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates significant corporate actions, including new financial obligations and equity transactions, which could impact the company's financial structure and shareholder value.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements, financial obligations, and unregistered sales of equity, suggesting potential financial shifts and corporate restructuring.
Key Players & Entities
- Scorpius Holdings, Inc. (company) — Registrant
- NightHawk Biosciences, Inc. (company) — Former Company Name
- HEAT BIOLOGICS, INC. (company) — Former Company Name
- May 30, 2025 (date) — Date of earliest event reported
- 20250603 (date) — Filing Date
FAQ
What specific material definitive agreement was entered into by Scorpius Holdings, Inc.?
The filing indicates the entry into a material definitive agreement, but the specific details of this agreement are not provided in the provided text.
What is the nature of the direct financial obligation or off-balance sheet arrangement reported?
The filing states the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, but the specifics are not detailed in the provided text.
What were the circumstances of the unregistered sales of equity securities?
The filing reports unregistered sales of equity securities, but the details regarding the number of shares, price, or purchasers are not included in the provided text.
When did Scorpius Holdings, Inc. change its name from NightHawk Biosciences, Inc.?
The date of the name change from NightHawk Biosciences, Inc. to Scorpius Holdings, Inc. was May 2, 2022.
What is the Standard Industrial Classification code for Scorpius Holdings, Inc.?
The Standard Industrial Classification code for Scorpius Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding Scorpius Holdings, Inc. (SCPX).